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Abstract
Recent proteomics studies suggest high abundance and a much wider role for lysine acetylation (K-Ac) in cellular functions.
Nevertheless, cross influence between K-Ac and other post-translational modifications (PTMs) has not been carefully
examined. Here, we used a variety of bioinformatics tools to analyze several available K-Ac datasets. Using gene ontology
databases, we demonstrate that K-Ac sites are found in all cellular compartments. KEGG analysis indicates that the K-Ac sites
are found on proteins responsible for a diverse and wide array of vital cellular functions. Domain structure prediction shows
that K-Ac sites are found throughout a wide variety of protein domains, including those in heat shock proteins and those
involved in cell cycle functions and DNA repair. Secondary structure prediction proves that K-Ac sites are preferentially
found in ordered structures such as alpha helices and beta sheets. Finally, by mutating K-Ac sites in silico and predicting the
effect on nearby phosphorylation sites, we demonstrate that the majority of lysine acetylation sites have the potential to
impact protein phosphorylation, methylation, and ubiquitination status. Our work validates earlier smaller-scale studies on
the acetylome and demonstrates the importance of PTM crosstalk for regulation of cellular function.
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Introduction
Protein post-translational modification has emerged as a major
contributor to variation, localization and control of proteins. It has
been suggested that the incongruity between the complexity of
vertebrate organisms and the size of their encoded genomes is
compensated by the large number of PTMs available [1]. Of the
hundreds of PTMs identified, the most intensively studied is
protein phosphorylation, in which protein kinases (PK) attach
phosphate moieties to Ser, Thr, or Tyr residues. Protein
phosphorylation appears to play an essential role in many diverse
and critical cellular processes, and inhibitors of their function have
emerged as important modes of therapy for malignant diseases.
Acetylation of histone proteins was discovered almost 50 years
ago [2] and has long been associated with regulation of chromatin
structure [3]. Recent proteomics studies identified almost 5000
acetylation sites across almost 2000 proteins [4,5,6]. These
substrates of lysine acetylation are prevalent not only in the
nuclei, but also in other cellular compartments, such as the
cytoplasm, mitochondria, and the plasma membrane [4,5,6].
Furthermore, this PTM is known to involve such diverse cellular
processes such as signal transduction, cytoskeletal dynamics, and
membrane stability, prompting the observation that acetylation is
analogous to phosphorylation [7,8].
In addition to acetylation, the lysine side chain has been found
to be the target of numerous other modifications such as
ubiquitination, sumoylation, methylation, neddylation, propiony-
lation, and butylation [9,10,11,12,13]. Evidence suggests that
acetylation and other PTMs form complex regulatory networks,
and this ‘‘crosstalk’’ is the basis for a protein modification code
[1,14,15]. Hunter describes both positive and negative crosstalk.
In the former, a PTM signals the addition or removal of another
PTM or creates conditions favorable for the binding of a protein
that performs the second modification. Negative crosstalk can
result from direct competition for modification of a single residue
(e.g., among acetylation, butyrylation, methylation, and ubiquiti-
nation at the same lysine residue), while another mechanism is the
masking of a binding site, preventing the action of a modifying
protein. Multisite PTMs appear to act in sequential and/or
combinatorial ways [16,17] and seem to generate complex
programs of regulation and signaling [18,19]. For example,
multiple enzymes appear to phosphorylate histone protein H3 at
residue Ser10 [20,21,22], which appears to stimulate acetylation at
Lys14 (positive crosstalk) [20]. Conversely, this phosphorylation
blocks acetylation and methylation at Lys9 in the same protein
(negative crosstalk) [23].
Recently, a genome-wide analysis of single nucleotide polymor-
phisms (SNPs) found that around 70% of SNPs that lead to a
change in peptide sequence (non-synonymous SNPs, nsSNPs)
potentially affect protein phosphorylation status and play an
important role in cancer and other diseases [24]. Based on the
abundance of potential acetylation sites and their apparent
importance in a wide variety of cellular functions, the evidence
of PTM crosstalk, and these recent findings relating genome-wide
SNP changes to changes in phosphorylation status, we sought to
better define the acetylome. Here we present the first compre-
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analysis of cross-species conservation, a survey of domain and
secondary structure, gene ontology and pathway analysis, and a
study of potential crosstalk between and among these and other
PTMs. This comprehensive global survey of acetylation sites and
their interaction with other PTMs will serve to provide valuable
substrate for future study of protein modifications in health and
disease.
Results
Data Integration
Several sources are available for lysine acetylation substrates,
and we collected information from three sources with the largest
datasets (Figure 1): (i) the PhosphoSitePlus database, [25]) (a
manually curated database of PTMs), (ii) Uniprot [26,27] (a
comprehensive database of protein sequence and annotation data),
and (iii) 3,600 lysine acetylation sites from 1,750 proteins,
identified by mass spectrometry [5]. Because of inconsistencies
and slight variations present in the exact location reported for the
acetylated lysine residue, we used BLAST-P to map protein
sequences to the International Protein Index (IPI) database (v.
3.69) [28]. Sites redundant across the datasets were condensed. In
all, we identified 5,695 unique lysine acetylation sites across 2,834
IPI entries. The full list of acetylation sites and corresponding IPI
numbers are listed in Table S1. We derived a list of
phosphorylation sites in a similar manner, using three sources:
PhosphoSitePlus, Uniprot, and Phospho.ELM, [29]. We stan-
dardized the phosphorylation position according to the IPI
designation using BLAST-P. We identified 32,702 serine phos-
phorylation sites across 6,957 IPI entries, 9,293 threonine
phosphorylation sites across 4,026 IPI entries, and 10,277 tyrosine
phosphorylation sites across 4,656 IPI entries.
Conservation of lysine acetylation sites between mouse
and human
A high degree of interspecies conservation has been reported for
lysine acetylation [30] as well as histone deacetylases [31]. We
were interested in demonstrating the evolutionary conservation of
our identified lysine acetylation sites between human and mouse
genomes. We used BLAST-P to compare 87,130 human protein
sequences to 56,737 mouse protein sequences downloaded from
IPI. Overall, we found an amino acid conservation of 84.8%.
Lysine residues were conserved at a rate of 87.0%. Of the 5,695
acetylated lysine residues in 2,384 proteins identified above, we
were able to identify homologous sites in mouse for 5,290 lysine
residues (92.9%, p=1.78610
26) over 2,256 proteins (94.6%,
p=7.70610
24), demonstrating a very high degree of conservation
for this PTM and implicating these as likely functional lysine
acetylation sites in the mouse.
Subcellular localization of K-Ac substrate proteins
In order to further characterize lysine acetylation across the
proteome, we investigated the cellular localizations for our
identified acetylated lysine PTMs. The gene ontology annotations
for identified IPI genes were obtained from the GOA database
[32]. Of the 2,384 human proteins found with acetylated lysine
residues, 499 (20.9%) localized solely to the nucleus, 488 (20.5%)
were found only in the cytoplasm, and 182 (7.6%) were only in
mitochondria (Figure 2). The remaining proteins were either in an
unknown location (570, 23.9%) or in some combination of the
above locales (645, 27.2%). Therefore, as many as 1,885 (79.0%)
of identified proteins may be found outside of the nucleus,
supporting the recent evidence that non-histone proteins are a
major group of K-Ac targets [4,5,6].
Biologic pathway analysis
We surveyed the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database [33] to determine which pathways were
enriched for the proteins we identified above. Our data reveal
that acetylation of lysine is a common PTM across a diverse array
of cellular processes such as those involved in cell cycle and
peroxisome metabolism (Figure 3). Additionally, enrichment of K-
Ac substrates was observed for cellular processes involving cellular
communication, cytoskeletal assembly and maintenance, as well as
those important in maintaining localization. Several pathways
Figure 1. Data source and analyses. Lysine acetylation sites were collected from three sources; PhosphositePlus, Uniprot, and from the work of
Choudhary, et al. BLAST-P was used to map each acetylation site to the corresponding IPI protein. The data were condensed to remove redundant
sites. Subsequent analyses included conservation studies, subcellular localization, pathway analysis, domain analysis, secondary structure prediction,
and crosstalk prediction. Details and methods are outlined in the text.
doi:10.1371/journal.pone.0028228.g001
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including spliceosome, proteasome and ribosome assembly, tRNA
synthesis as well as DNA repair and replication. A wide and
diverse array of important metabolic pathways were found to be
enriched, including those involving amino acid metabolism,
glycolysis and gluconeogeneis, and fatty acid metabolism.
Interestingly, among environmental information processing path-
ways, the mTOR signaling pathway was found to be enriched,
which is highly connected with cellular energy metabolism. We
also found significant enrichment of K-Ac proteins in both the
monogenetic disease Huntington’s chorea as well as complex,
multifactorial disorders such as Parkinson’s disease, Alzheimer’s
disease, and systemic lupus erythematosus (SLE). Finally, proteins
with acetylated lysine were found enriched in several oncologic
processes such as prostate and pancreatic cancers as well as
chronic myelogenous leukemia (CML). Among the processes
found to have underrepresentation of K-Ac proteins were
cytokine-cytokine receptor interactions and neuroactive ligand-
receptor interactions. The underrepresentation of these processes
may be due in part from the fact that the proteins involved may
not be expressed in the cell lines or tissues from which the data are
derived. In addition, as with other global measures of gene and
protein expression, results may be biased by the abundance of
substrate. In all, lysine acetylation was found to be a common
PTM in a wide variety of crucial cellular functions and in several
important diseases and oncologic processes.
Domain analysis
The domain structure surrounding acetylation sites may give
important insight into the function, regulation and importance of
K-Ac as a PTM. We investigated the functional domains
containing K-Ac proteins. Domain information was obtained
from the NCBI Conserved Domain Database (CDD [34,35]), a
collection containing domain information from NCBI-curated
domains as well as domain models from other sources. Proteins
containing K-Ac were aligned to the distribution of CDD domains
using Reverse-PSI BLAST (RPS-BLAST) [28], and a two-tailed
Fisher’s exact test was used to test the distribution of K-Ac sites
within each domain against all IPI proteins. In total, 737 domains
were observed to contain K-Ac sites, and of these, 26 were over-
represented for K-Ac sites (Figure 4, Table S2). False discovery
rate calculations were performed to account for multiple
hypothesis testing, and domains with an FDR,0.01 were
considered significant. One of the domains found to be most
enriched was pfm00183 (Hsp90). Heat shock protein 90 is a
molecular chaperone essential for the regulation of many signaling
proteins and is subjected to various PTMs, including phosphor-
ylation [36] and acetylation [37,38]. Not surprisingly, the cl0074
domain of the core histone proteins H2A/H2B/H3 and H4 was
found to be enriched for K-Ac. Several domains enriched for K-
Ac were found within metabolic enzymes, such as pfam00285
(citrate synthase), pfam00026 (aspartyl protease), and cl00445
(isocitrate dehydrogenase). Other enriched domains were found to
be within the cytoskeletal protein actin (pfam00022)and the
membrane protein annexin (cl02574).
Secondary structure prediction
To further characterize lysine acetylation, we surveyed
secondary structure predictions using Uniprot and the Dictionary
of Protein Secondary Structure (DSSP), a database of secondary
structure assignment prediction based on primary sequence [39].
We found significant enrichment for K-Ac sites in alpha helices
(p=9.05610
241), beta-sheets (p,3.24610
24), and turns
(p,3.50610
22), while no enrichment was found in coiled-coils
(Figure 5). Given the evolutionary conservation of K-Ac sites
found and their importance in critical cellular functions, the high
degree of enrichment of K-Ac sites in ordered secondary structure
is not surprising.
Crosstalk
We are keenly interested in understanding how acetylation of
lysine residues can influence other PTMs, either at the same
location or at a nearby site, facilitating PTM crosstalk [15]. Our
data reveal that 1,165 (20.5%) of K-Ac sites are within ten residues
of known phosphorylation sites and that 2,121 (37.2%) of K-Ac
sites form acetylated lysine clusters with nearby K-Ac modifica-
tions (Table S3). These frequent associations suggest that PTM
crosstalk is common and likely represents a codified crosstalk
among and between these modifications.
Upon acetylation, the lysine side chain is changed as the acetyl
group neutralizes the positive charge and influences the ability to
form hydrogen bonds. Consequently, the nearby microenviron-
ment is modified compared to acetylation-free lysine. To better
model the impact of acetylation and its implications on PTM
crosstalk, we chose to perturb the microenvironment in silico
through substitution of lysine with glutamine (neutral side chain)
or leucine (hydrophobic side chain). To predict the impact of these
substitutions, we used NetPhosK 1.0, a software tool for modeling
phosphorylation sites based on kinase-specific predictions [40,41].
We compared the software-predicted phosphorylation sites and
kinase binding sites near acetylated lysines to the predictions
following lysine substitution with either glutamine or leucine.
When a leucine is substituted for lysine at a K-Ac site, 4,191
neighboring phosphorylation sites in the vicinity of 2,926 (51.4%)
sites are affected (Figure 6). We classified the affected phosphor-
ylation sites into five categories: Types I and II: gain and loss of a
phosphorylation site, respectively; Type III: retention of a
phosphorylation site and gain of a new kinase binding site; Type
IV: retention of a phosphorylation site but loss of kinase binding
site; Type V: loss of an endogenous kinase binding site with
Figure 2. Subcellular localization of acetylated lysine residues.
The gene ontology annotations for identified IPI genes were obtained
from the GOA database. Of the 2384 lysine acetylation genes identified,
488 (20.4%) are exclusively nuclear, 182 (7.6%) are mitochondrial only,
and 499 (20.9%) are only found in the cytoplasm. 570 proteins (23.9%)
were not assigned to any compartment.
doi:10.1371/journal.pone.0028228.g002
Bioinformatics of Lysine Acetylation
PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28228Figure 3. Biologic pathway analysis. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG), we identified pathways enriched for the
acetylated proteins identified. False discovery rate control was used to correct for multiple hypothesis testing, the KEGG pathways with a corrected
p-value,0.01 were considered significant. A diverse array of cellular pathways and functions were identified including those involved in cellular
processes (light green), genetic information processing (red), human diseases (indigo), metabolism (yellow).
doi:10.1371/journal.pone.0028228.g003
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lysine, a significant number of sites lose their phosphorylation
propensity (35%, Type II) or lose their kinase binding site (29%,
Type IV). Conversely, the number of phosphorylation sites gained
is small (10%, Type I), as is the number of kinase binding sites
gained (16%, Type III). The phosphorylation site influenced is
most often distributed within five residues of the acetylation site,
with upstream sites being more affected than downstream ones
(Figure S1). When glutamine was substituted, similar results were
obtained (Figure 6, Figure S1). Of 5,695 K-Ac sites, 2,647
phosphorylation sites were directly affected (46.0%), as well as
3,625 neighboring sites.
Similarly, we extended our crosstalk analysis to examine the
effects of lysine acetylation on ubiquitination and methylation
(Table S4 and S5). To accomplish this, we used BPB-PPMS, an in
silico tool for methylation prediction [42] and UbPred, a predictor
of potential ubiquitination sites [43]. We compared the predicted
methylation and ubiquination sites around acetylated lysines to the
predictions after substitution with leucine or glutamine. We used
the author-suggested cutoffs of 0.8 (methylation prediction) and
0.84 (ubiquitination prediction), and tallied the sites where
methylation and ubiquitination were affected by changing the
lysine to either leucine or glutamine. Because leucine and
glutamine cannot be methylated or ubiquitinated, a substitution
of lysine to leucine or glutamine eliminates the potential for self-
modification. We classified the changes into three groups: Type I:
gain of a methylation or ubiquitination on a nearby lysine; Type
IIs (self): loss of methylation or ubiquitination on the lysine itself;
Type IIn (neighbor): loss of methylation or ubiquitination on a
nearby lysine. Seventy-six (1.3%) and 75 (1.3%) of the 5,695
acetylated lysines are predicted to have a direct or indirect effect
on methylation sites when the lysine is substituted to leucine or
glutamine respectively (Figure 6, middle). In the case of leucine
substitution, 25% of the changes are predicted to be the gain of a
surrounding methylation site (Type I), 41% are the loss of a
methylation site on the lysine itself (Type IIs), and 34% are the loss
of a nearby methylation site (Type IIn). Likewise, glutamine
substitution results a change of 75 methylation sites, of which 9.2%
are the gain of a surrounding site (Type I), 42% the direct loss of a
Figure 4. Domain analysis. Proteins with acetylated lysines were aligned to the distribution of domains in the NCBI Conserved Domain Database
using PRS-BLAST. Correction for multiple hypothesis testing was carried out using standard false discovery rate control methods, and domains with a
corrected p-value,0.01 were considered significant. Domains with more than the number expected K-Ac sites were considered ‘‘overrepresented.’’
doi:10.1371/journal.pone.0028228.g004
Figure 5. Secondary structure prediction. The secondary structure
of acetylated proteins was derived from Uniprot and the Dictionary of
Protein Secondary Structure (DSSP). There was significant enrichment of
acetylated lysine sites in alpha helices and beta-sheets only.
doi:10.1371/journal.pone.0028228.g005
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methylation site (Type IIn). The methylation site affected is most
often within five residues of the lysine (Figure S2). Comparatively,
the predicted crosstalk between lysine acetylation and ubiquitina-
tion is much greater (Figure 6, bottom). In all, 552 (9.7%) K-Ac
sites and 517 (9.1%) K-Ac sites show direct or indirect crosstalk
with ubiquitination, respectively. For leucine substitution, 41% of
the changes are the gain of a nearby ubiquitination site (Type 1),
while the substitution results in the loss of a ubiquitination site on
the lysine itself 27% of the time (Type IIs) and on a nearby lysine
32% of the time (Type IIn). Substitution by glutamine yields
similar results as outlined in Figure 6. The affected ubiquitination
site is most often within ten residues of the lysine, but can be as far
away as 40 residues (Figure S3). These results implicate the acetyl
group as having a drastic effect on the lysine microenvironment,
leading the way for crosstalk between lysine acetylation and
nearby phosphorylation methylation, or ubiquitination status.
Discussion
Our early proteomics studies of lysine acetylation indicate that
K-Ac is a highly abundant PTM that is enriched in mitochondria
and in metabolic enzymes [4]. Similar studies in E. coli suggest an
evolutionarily conserved role for K-Ac in metabolism [30]. Recent
studies from others, taking advantage of more advanced mass
spectrometer systems, describe the distribution of acetylated lysine
residues and their involved functions in three human cell lines [5],
human liver tissue [6], and Salmonella enterica [44]. To understand
their true contribution to spatial and temporal functions, a
comprehensive map of K-Ac sites along with their dynamic
profiling under diverse physiologic conditions needs to be
constructed.
Our integrated data analyses reveal that a large fraction of
lysine acetylation sites are in known functional domains and
involved in multiple known pathways. This supports the theory
that various domains can communicate to couple PTMs to the
organization of the cell [45]. Furthermore, the high conservation
of K-Ac sites suggests that lysine acetylation events are under
positive selection pressure because of their essential functions. One
must be careful in interpreting these results, as they may be
affected by the abundance of proteins. As with gene expression
and proteomics studies, results may be biased towards the most
prevalent genes and proteins. Nevertheless, with this caveat, the
widespread presence of lysine acetylation sites is revealing.
Using a substantially larger and more diverse dataset, we
recapitulated several exercises performed by Choudhary, et al., and
several important differences are noted. First, our data reveal a
more substantial overlap of localization across subcellular domains
(Figure 2), likely owing to the diverse array of proteins represented.
In the Choudhary analysis, mention of localization overlap is only
made for the nuclear and cytosolic compartments, while in our
analysis, we found significant overlap additionally with the
mitochondrial compartment. Indeed, we found 1,133 (47.2%) of
the proteins to be localized in more than one compartment
(Figure 2). Second, our findings suggest that while the majority of
Figure 6. Crosstalk prediction. Top: (A) The influence of acetylated
lysine on neighboring phosphorylation sites was predicted by
substituting a leucine for a lysine at all predicted K-Ac sites and then
predicting potential phosphorylation sites using NetPhosK 1.0. (B) In all,
51% of nearby phosphorylation sites were affected, and these were
classified as Type I (gain of a phosphorylation site, 10%), Type II (loss of
a phosphorylation site, 35%), Type III (retention of a phosphorylation
site with gain of kinase binding site, 16%), Type IV (retention of a
phosphorylation site with loss of kinase binding site, 29%), and Type V
(loss of an endogenous kinase binding site with concomitant gain of a
new one, 10%). This analysis was repeated by substituting glutamine for
lysine (Panels C and D). This analysis was repeated for methylation using
BPB-PPMS (middle) and ubiquitination using UbPred (bottom). For
further details, see text.
doi:10.1371/journal.pone.0028228.g006
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helices (Figure 5), while Choudhary identified most K-Ac sites in
coiled regions. While it is difficult to make generalizations about
the implications of this finding, one intriguing explanation for at
least part of this enrichment is that the acetylation of lysine is
known to be destabilizing to alpha helices [46,47], and this may be
responsible for changes in higher-order folding such as seen in
nucleosomes [48]. Finally, our analysis (Figure 4) revealed
significant enrichment for K-Ac residues in chaperones HSP70
and HSP90, likely reflecting the importance of post-translational
modification in their regulation.
Several models have been proposed to interpret the crosstalk
between acetylation of lysine and other PTMs. Yang, et al. has
summarized these potential interactions and postulates the
mechanisms by which lysine acetylation can program protein
function [31]. A cluster of autoacetylated lysines within the
acetyltransferase CBP/p300 forms a charged patch that can act as
an activation switch [49]. Indeed, in our data, 34.2% of K-Ac sites
have neighboring lysines with the potential to be acetylated. A
more difficult analysis is to predict autoacetylation between
adjacent subunits of a homodimer, as in the case of CBP/p300,
which appears also to be acetylated via intermolecular mecha-
nisms [50].
Lysine acetylation can alter protein function through bromo-
domain binding, as when p53 forms docking sites for transcrip-
tional coactivators such as the CBP [15,51]. Another study reports
that Salmonella enterica synthetase is modulated through lysine
acetylation [52]. Finally, some nuclear receptors appear to be
regulated by acetylation status, such as deacetylation of Liver X
receptor by SIRT1 [53].
Beyond affecting neighboring lysine residues, acetylation has the
potential to communicate with surrounding phosphorylation,
methylation and ubiquitination sites. Acetylation of p53 at
Lys370 and Lys372 impacts phosphorylation of Ser371, affecting
downstream signaling and function [54]. We identified over 4,000
phosphorylation sites that could potentially be influenced by
nearby lysine acetylation. Phosphorylation could be affected
through the creation or destruction of a phosphorylation site or
through alterations in kinase binding (Figure 6). These findings are
supported by earlier work demonstrating similar changes in
phosphorylation sites and kinase binding domains due to
alterations in phosphorylation status [24,55]. Positive crosstalk
has been reported between acetylation of Lys14 and phosphory-
lation of Ser10 in histone H3 [20], and our findings correctly
predict this interaction. We found less than 80 methylation sites
potentially affected by lysine acetylation, but this number may
increase as more PTMs are identified. Acetylation and methyla-
tion on H3 Lys-9 have been reported to be mutually exclusive and
associated with active and repressive gene expression, respectively
[23]. Our predictions for this protein are consistent with these
findings. Further, our simulations predict that over 600 ubiquiti-
nation sites may be affected by lysine acetylation, and this may
have a profound impact on cellular degradation pathways. These
findings are supported by recent work identifying extensive
overlap between lysine acetylation and ubiquitination [56,57].
Finally, the dataset described in this paper will assist researchers in
the community in testing the possible interactions between lysine
acetylation and other modifications.
Cellular localization can also be influenced through lysine
acetylation. Acetylation by CBP of FoxO transcription factors
promotes phosphorylation of Ser256, leading to cytoplasmic
retention [58]. In addition, the acetylated lysines are in the
DNA binding domain and could thus impede nuclear import. Our
work demonstrates that acetylation sites are distributed throughout
the cytoplasm, mitochondria, and nucleus, providing fertile
substrate for such localization control (Figure 2).
It is therefore apparent that acetylation of lysine is one of many
PTMs involved in a complicated language of crosstalk and
communication that maintains delicate control within the cell.
This PTM code was first described for p53 [15] but has now been
extended to many other genes and pathways [59,60,61]. Indeed,
our work has demonstrated the broad range of biologic pathways
(Figure 3) and domains (Figure 4) that harbor acetylated lysine
residues. This wide distribution of PTMs and the dependent
relationship between acetylation, phosphorylation, methylation,
ubiquitination, and other PTMs strongly implies that crosstalk is a
common mechanism and enables the organism to finely tune
protein functions at the translational level. In fact, the high degree
of evolutionary conservation of lysine acetylation [62] implies a
similar degree of conservation and more broad implications for the
crosstalk mechanisms described here. In transcriptional regulation,
it is known that factors with opposing activity can bind regulatory
elements of the same gene [63], and these ‘‘dual genes’’ can tune
expression more precisely and under more stringent control. In a
similar fashion, it is likely that PTMs may exert an analogous
effect, yet it is unclear how extensive this control is, and therefore a
more complete PTM dataset and further investigation is
warranted.
Materials and Methods
Data collection and integration
All scripts were written in Perl and are available upon request.
Acetylated lysine sites were collected from three sources:
PhosphoSitePlus [25], Uniprot [26,27], and from a paper reported
by Choudhary and his colleagues [5]. Protein-BLAST (BLAST-P,
basic local alignment search tool) was used to map protein
sequences to an IPI database (v3.69) [28]. Phosphorylation sites
were derived in a similar manner, using PhosphoSitePlus, Uniprot
and Phospho.ELM [29]. The lists were consolidated to remove
any redundant sites.
Conservation of K-Ac sites between human and mouse
Using BLAST-P, we compared 87,130 human protein sequenc-
es and 56,737 mouse protein sequences from the IPI database.
Using a significance e-value of 10
26, we compared the amino acid
sequence conservation between human and mouse in order to
determine the conservation across the K-Ac residues identified
during our data integration phase. A Fisher’s exact test was used to
determine the significance of the conservation rate to all amino
acids and to only lysine residues.
Subcellular localization of acetylated lysine residues
We queried the Gene Ontology Annotation database (GOA)
[32] with the IPI numbers of our identified K-Ac genes to get the
cellular component annotation. Using this information, we
determined the subcellular localizations of these gene products.
Biologic pathway analysis
We used the Kyoto Encyclopedia of Genes and Genomes
(KEGG [64]) to identify enriched pathways. A two-tailed Fisher’s
exact test was employed to test the enrichment of the K-Ac-
containing IPI entries against all IPI proteins. Correction for
multiple hypothesis testing was carried out using standard false
discovery rate control methods. The KEGG pathways with a
corrected p-value,0.01 were considered significant. These
pathways were classified into hierarchical categories according to
the KEGG website.
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Using our K-Ac-containing proteins, we searched the NCBI
Conserved Domain Database (CDD) using reverse PSI-BLAST
(reverse position specific iterative BLAST, RPS-BLAST) [34,35].
A two-tailed Fisher’s exact test was used to compare the
distribution of K-Ac sites within each domain to the ratio over
all proteins. Correction for multiple hypothesis testing was carried
out using standard false discovery rate control methods, and
domains with a corrected p-value,0.01 were considered signifi-
cant. Domains with more than the number expected K-Ac sites
were considered ‘‘overrepresented,’’ while those with fewer-than-
expected K-Ac sites were categorized as ‘‘underrepresented.’’
Secondary structure prediction
We derived secondary structure information from the Dictio-
nary of Protein Secondary Structure (DSSP [39]) as well as the
Uniprot database.
Crosstalk prediction
To survey the contribution of K-Ac to the modification capacity
of nearby sites, we choose two other amino acids – glutamine (Q)
and leucine (L) as substitutes for lysine. NetPhosK 1.0 [40,41] was
employed to predict kinase-specific phosphorylation for nearby
sites, using the default program settings. The sites where the
phosphorylation binding site or the kinase binding were affected
by the change from K to Q or L were tallied. We classified the
affected phosphorylation sites into five categories: Types I and II:
gain and loss of a phosphorylation site, respectively; Type III:
retention of a phosphorylation site and gain of a new kinase
binding site; Type IV: retention of a phosphorylation site but loss
of kinase binding site; Type V: loss of an endogenous kinase
binding site with simultaneous gain of a new one.
In addition to phosphorylation, we studied the effects on
ubiquitination using UbPred (cutoff 0.84) [43] and on methylation,
using BPB-PPMS (cutoff 0.8) [42]. In a similar fashion, the
contribution of lysine substitution by either leucine or glutamine
was studied. Since neither can be methylated or ubiquitinated,
substitution resulted in a loss of self-modification. We classified the
changes into three groups: Type I: gain of a methylation or
ubiquitination on a nearby lysine; Type IIs (self): loss of
methylation or ubiquitination on the lysine itself; Type IIn
(neighbor): loss of methylation or ubiquitination on a nearby
lysine.
Supporting Information
Figure S1 Distance distribution of altered phosphory-
lation sites. Each acetylated lysine was substituted with leucine
(top) or glutamine (bottom). The neighborhood surrounding the
K-Ac was searched for potential phosphorylation sites. The
number of altered phosphorylation sites within 10 residues of the
K-Ac site are plotted. For further details, refer to the text.
(TIFF)
Figure S2 Distance distribution of altered methylation
sites. Each acetylated lysine was substituted with leucine (top) or
glutamine (bottom). The neighborhood surrounding the K-Ac was
searched for potential methylation sites, and these are plotted. All
changes were found within five residues of the K-Ac. For further
details, refer to the text.
(TIFF)
Figure S3 Distance distribution of altered ubiquitina-
tion sites. Each acetylated lysine was substituted with leucine
(top) or glutamine (bottom). The neighborhood surrounding the
K-Ac was searched for potential ubiquination sites, and these are
plotted. For further details, refer to the text.
(TIFF)
Table S1 All identified acetylation sites. These are the
complete data for the identified acetylation sites. For details, refer
to text.
(PDF)
Table S2 Domain enrichment. These are the complete data
for Figure 4. Proteins with acetylated lysines were aligned to the
distribution of domains in the NCBI Conserved Domain Database
using PRS-BLAST. The distribution was tested against that of all
IPI proteins using a two-tailed Fisher’s exact test.
(PDF)
Table S3 Phosphorylation sites affected. NetPhosK 1.0
was employed to predict kinase-specific phosphorylation for
nearby sites, using the default program settings. The sites where
the phosphorylation binding site or the kinase binding were
affected by the change from K to Q or L were tallied.
(PDF)
Table S4 Methylation sites affected. We studied the effects
on methylation using BPB-PPMS (cutoff 0.8). The contribution of
lysine substitution by either leucine or glutamine was studied.
(PDF)
Table S5 Ubiquitination sites affected. We studied the
effects on ubiquitination using UbPred (cutoff 0.84). The
contribution of lysine substitution by either leucine or glutamine
was studied.
(PDF)
Author Contributions
Conceived and designed the experiments: ZL SLV ZC YZ. Performed the
experiments: ZL SLV ZC YZ. Analyzed the data: ZL SLV ZC YZ.
Contributed reagents/materials/analysis tools: ZL SLV ZC YZ. Wrote the
paper: ZL SLV YZ.
References
1. Hunter T (2007) The age of crosstalk: phosphorylation, ubiquitination, and
beyond. Mol Cell 28: 730–738.
2. Allfrey VG, Mirsky AE (1964) Structural Modifications of Histones and their
Possible Role in the Regulation of RNA Synthesis. Science 144: 559.
3. Pazin MJ, Kadonaga JT (1997) What’s up and down with histone deacetylation
and transcription? Cell 89: 325–328.
4. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, et al. (2006) Substrate and functional
diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 23:
607–618.
5. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, et al. (2009) Lysine
acetylation targets protein complexes and co-regulates major cellular functions.
Science 325: 834–840.
6. Zhao S, Xu W, Jiang W, Yu W, Lin Y, et al. (2010) Regulation of cellular
metabolism by protein lysine acetylation. Science 327: 1000–1004.
7. Norris KL, Lee J-Y, Yao T-P (2009) Acetylation goes global: the emergence of
acetylation biology. Sci Signal 2: pe76.
8. Kouzarides T (2000) Acetylation: a regulatory modification to rival phosphor-
ylation? EMBO J 19: 1176–1179.
9. Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the
molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164–171.
10. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, et al. (2004) Regulation of
p53 activity through lysine methylation. Nature 432: 353–360.
11. Feng L, Lin T, Uranishi H, Gu W, Xu Y (2005) Functional analysis of the roles
of posttranslational modifications at the p53 C terminus in regulating p53
stability and activity. Mol Cell Biol 25: 5389–5395.
12. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, et al. (1998) DNA damage
activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12:
2831–2841.
Bioinformatics of Lysine Acetylation
PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e2822813. Chen Y, Sprung R, Tang Y, Ball H, Sangras B, et al. (2007) Lysine
propionylation and butyrylation are novel post-translational modifications in
histones. Mol Cell Proteomics 6: 812–819.
14. Caron C, Boyault C, Khochbin S (2005) Regulatory cross-talk between lysine
acetylation and ubiquitination: role in the control of protein stability. Bioessays
27: 408–415.
15. Yang X-J, Seto E (2008) Lysine acetylation: codified crosstalk with other
posttranslational modifications. Mol Cell 31: 449–461.
16. Garcia BA, Pesavento JJ, Mizzen CA, Kelleher NL (2007) Pervasive
combinatorial modification of histone H3 in human cells. Nat Methods 4:
487–489.
17. Taverna SD, Ueberheide BM, Liu Y, Tackett AJ, Diaz RL, et al. (2007) Long-
distance combinatorial linkage between methylation and acetylation on histone
H3 N termini. Proc Natl Acad Sci USA 104: 2086–2091.
18. Choudhary C, Mann M (2010) Decoding signalling networks by mass
spectrometry-based proteomics. Nat Rev Mol Cell Biol 11: 427–439.
19. Yang X-J (2005) Multisite protein modification and intramolecular signaling.
Oncogene 24: 1653–1662.
20. Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, et al. (2000)
Synergistic coupling of histone H3 phosphorylation and acetylation in response
to epidermal growth factor stimulation. Mol Cell 5: 905–915.
21. Hsu JY, Sun ZW, Li X, Reuben M, Tatchell K, et al. (2000) Mitotic
phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1
phosphatase in budding yeast and nematodes. Cell 102: 279–291.
22. Latham JA, Dent SYR (2007) Cross-regulation of histone modifications. Nat
Struct Mol Biol 14: 1017–1024.
23. Edmondson DG, Davie JK, Zhou J, Mirnikjoo B, Tatchell K, et al. (2002) Site-
specific loss of acetylation upon phosphorylation of histone H3. J Biol Chem 277:
29496–29502.
24. Ren J, Jiang C, Gao X, Liu Z, Yuan Z, et al. (2010) PhosSNP for systematic
analysis of genetic polymorphisms that influence protein phosphorylation. Mol
Cell Proteomics 9: 623–634.
25. Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E, Zhang B (2004)
PhosphoSite: A bioinformatics resource dedicated to physiological protein
phosphorylation. Proteomics 4: 1551–1561.
26. Boutet E, Lieberherr D, Tognolli M, Schneider M, Bairoch A (2007)
UniProtKB/Swiss-Prot. Methods Mol Biol 406: 89–112.
27. Consortium U (2010) The Universal Protein Resource (UniProt) in 2010.
Nucleic Acids Res 38: D142–148.
28. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local
alignment search tool. J Mol Biol 215: 403–410.
29. Diella F, Gould CM, Chica C, Via A, Gibson TJ (2008) Phospho.ELM: a
database of phosphorylation sites–update 2008. Nucleic Acids Res 36:
D240–244.
30. Zhang J, Sprung R, Pei J, Tan X, Kim S, et al. (2009) Lysine acetylation is a
highly abundant and evolutionarily conserved modification in Escherichia coli.
Mol Cell Proteomics 8: 215–225.
31. Yang X-J, Seto E (2008) The Rpd3/Hda1 family of lysine deacetylases: from
bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 9: 206–218.
32. Barrell D, Dimmer E, Huntley RP, Binns D, O’Donovan C, et al. (2009) The
GOA database in 2009–an integrated Gene Ontology Annotation resource.
Nucleic Acids Res 37: D396–403.
33. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, et al. (2006) From
genomics to chemical genomics: new developments in KEGG. Nucleic Acids
Res 34: D354–357.
34. Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C,
et al. (2009) CDD: specific functional annotation with the Conserved Domain
Database. Nucleic Acids Res 37: D205–210.
35. Marchler-Bauer A, Anderson JB, Derbyshire MK, DeWeese-Scott C,
Gonzales NR, et al. (2007) CDD: a conserved domain database for interactive
domain family analysis. Nucleic Acids Res 35: D237–240.
36. Mollapour M, Tsutsumi S, Neckers L (2010) Hsp90 phosphorylation, Wee1, and
the cell cycle. Cell cycle (Georgetown, Tex) 9.
37. Ai J, Wang Y, Dar JA, Liu J, Liu L, et al. (2009) HDAC6 regulates androgen
receptor hypersensitivity and nuclear localization via modulating Hsp90
acetylation in castration-resistant prostate cancer. Mol Endocrinol 23:
1963–1972.
38. Scroggins BT, Robzyk K, Wang D, Marcu MG, Tsutsumi S, et al. (2007) An
acetylation site in the middle domain of Hsp90 regulates chaperone function.
Mol Cell 25: 151–159.
39. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern
recognition of hydrogen-bonded and geometrical features. Biopolymers 22:
2577–2637.
40. Blom N, Gammeltoft S, Brunak S (1999) Sequence and structure-based
prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:
1351–1362.
41. Blom N, Sicheritz-Ponte ´n T, Gupta R, Gammeltoft S, Brunak S (2004)
Prediction of post-translational glycosylation and phosphorylation of proteins
from the amino acid sequence. Proteomics 4: 1633–1649.
42. Shao J, Xu D, Tsai S-N, Wang Y, Ngai S-M (2009) Computational identification
of protein methylation sites through bi-profile Bayes feature extraction. PLoS
ONE 4: e4920.
43. Radivojac P, Vacic V, Haynes C, Cocklin RR, Mohan A, et al. (2010)
Identification, analysis, and prediction of protein ubiquitination sites. Proteins
78: 365–380.
44. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, et al. (2010) Acetylation of
metabolic enzymes coordinates carbon source utilization and metabolic flux.
Science 327: 1004–1007.
45. Seet BT, Dikic I, Zhou M-M, Pawson T (2006) Reading protein modifications
with interaction domains. Nat Rev Mol Cell Biol 7: 473–483.
46. Batra PP, Roebuck MA, Uetrecht D (1990) Effect of lysine modification on the
secondary structure of ovalbumin. J Protein Chem 9: 37–44.
47. Xu X, Cooper LG, DiMario PJ, Nelson JW (1994) Helix formation in model
peptides based on nucleolin TPAKK motifs. Biopolymers 35: 93–102.
48. Tse C, Sera T, Wolffe AP, Hansen JC (1998) Disruption of higher-order folding
by core histone acetylation dramatically enhances transcription of nucleosomal
arrays by RNA polymerase III. Mol Cell Biol 18: 4629–4638.
49. Thompson PR, Wang D, Wang L, Fulco M, Pediconi N, et al. (2004) Regulation
of the p300 HAT domain via a novel activation loop. Nat Struct Mol Biol 11:
308–315.
50. Karanam B, Jiang L, Wang L, Kelleher NL, Cole PA (2006) Kinetic and mass
spectrometric analysis of p300 histone acetyltransferase domain autoacetylation.
J Biol Chem 281: 40292–40301.
51. Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, et al. (1999) Structure
and ligand of a histone acetyltransferase bromodomain. Nature 399: 491–496.
52. Starai VJ, Celic I, Cole RN, Boeke JD, Escalante-Semerena JC (2002) Sir2-
dependent activation of acetyl-CoA synthetase by deacetylation of active lysine.
Science (New York, NY) 298: 2390–2392.
53. Li X, Zhang S, Blander G, Tse JG, Krieger M, et al. (2007) SIRT1 deacetylates
and positively regulates the nuclear receptor LXR. Mol Cell 28: 91–106.
54. Kurash JK, Lei H, Shen Q, Marston WL, Granda BW, et al. (2008) Methylation
of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell 29:
392–400.
55. Ryu G-M, Song P, Kim K-W, Oh K-S, Park K-J, et al. (2009) Genome-wide
analysis to predict protein sequence variations that change phosphorylation sites
or their corresponding kinases. Nucleic Acids Res 37: 1297–1307.
56. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, et al. (2011) Systematic and
quantitative assessment of ubiquitin-modified proteome. Mol Cell 44: 325–340.
57. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, et al. (2011) A proteome-
wide quantative survey of in vivo ubiquitylation sites reveals widespread
regulatory roles. Mol Cell Proteomics 10: epub ahead of print.
58. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, et al. (2005)
Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to
phosphorylation. Proc Natl Acad Sci USA 102: 11278–11283.
59. Girdwood D, Bumpass D, Vaughan OA, Thain A, Anderson LA, et al. (2003)
P300 transcriptional repression is mediated by SUMO modification. Mol Cell
11: 1043–1054.
60. Huang H, Regan KM, Lou Z, Chen J, Tindall DJ (2006) CDK2-dependent
phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science
(New York, NY) 314: 294–297.
61. Vo N, Fjeld C, Goodman RH (2001) Acetylation of nuclear hormone receptor-
interacting protein RIP140 regulates binding of the transcriptional corepressor
CtBP. Mol Cell Biol 21: 6181–6188.
62. Weinert BT, Wagner SA, Horn H, Henriksen P, Liu WR, et al. (2011)
Proteome-Wide Mapping of the Drosophila Acetylome Demonstrates a High
Degree of Conservation of Lysine Acetylation. Sci Signal 4: ra48.
63. Aida M, Chen Y, Nakajima K, Yamaguchi Y, Wada T, et al. (2006)
Transcriptional pausing caused by NELF plays a dual role in regulating
immediate-early expression of the junB gene. Mol Cell Biol 26: 6094–6104.
64. Wiwanitkit V (2007) Type I diabetes mellitus in human and chimpanzee: a
comparison of kyoto encyclopedia of genes and genomes pathway. Diabetes
Technol Ther 9: 145–148.
Bioinformatics of Lysine Acetylation
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28228